News & Updates

Show Multimedia Only

New-found anti-ageing effects of GLP-1 RAs can potentially improve severe stroke recovery

03 Jun 2026 by

Researchers from the Chinese University of Hong Kong (CUHK) and the Gerald Choa Neuroscience Institute (GCNI) have achieved a breakthrough “bench-to-bedside” advancement, translating discovery of multi-omic ageing counteraction with glucagon-like peptide-1 (GLP-1) receptor agonism into a potential new treatment strategy for stroke.

New-found anti-ageing effects of GLP-1 RAs can potentially improve severe stroke recovery

03 Jun 2026

Award-winning world-first nasal spray as prehospital emergency aid for ischaemic stroke

03 Jun 2026 by

Researchers from the University of Hong Kong (HKU) have developed the world’s first NanoPowder nasal spray for use as prehospital emergency treatment at the onset of an ischaemic stroke, which can potentially reduce brain damage by >80 percent and substantially increase stroke survival rates and neurological recovery, representing a significant advancement in stroke management globally.

Award-winning world-first nasal spray as prehospital emergency aid for ischaemic stroke

03 Jun 2026

Mainland China’s healthcare surge and HK’s edge: A powerful synergy

03 Jun 2026 by

Mainland China’s growing investment in medicine and biopharma is reshaping its research and healthcare landscape while creating new opportunities for Hong Kong – to contribute to, and benefit from – the next phase of development, noted Professor Chak-Sing Lau, Dean of Medicine, University of Hong Kong (HKU), at the 30^th Hong Kong Medical Forum

Mainland China’s healthcare surge and HK’s edge: A powerful synergy

03 Jun 2026

Astegolimab gets mixed results in COPD

02 Jun 2026

In the treatment of patients with chronic obstructive pulmonary disease (COPD), use of the anti-ST2 human IgG2 monoclonal antibody astegolimab every 2 weeks helps reduce the frequency of exacerbations compared with placebo in a phase 2b trial but not in a phase 3 trial.

Astegolimab gets mixed results in COPD

02 Jun 2026

Leflunomide–hydroxychloroquine’s efficacy in Sjögren’s disease confirmed in RepurpSS-II trial

02 Jun 2026 by

Treatment with leflunomide in combination with hydroxychloroquine has been proven to be beneficial, helping reduce disease activity in patients with systemically active Sjögren’s disease, in the phase 2b RepurpSS-II trial.

Leflunomide–hydroxychloroquine’s efficacy in Sjögren’s disease confirmed in RepurpSS-II trial

02 Jun 2026

Can HF patients with obesity undergo metabolic, bariatric procedures?

02 Jun 2026

Undergoing metabolic and bariatric procedures (MBP) is feasible in some adults with obesity and heart failure (HF), according to a study.

Can HF patients with obesity undergo metabolic, bariatric procedures?

02 Jun 2026

Corticosteroid-sparing topical treatments safe, efficacious for VKC in children

02 Jun 2026 by

Treatment with corticosteroid-sparing topical interventions such as cyclosporine, tacrolimus, sodium cromoglycate, and interferon alpha-2 demonstrates efficacy in improving the signs and symptoms of vernal keratoconjunctivitis (VKC) in children, as shown in a study.

Corticosteroid-sparing topical treatments safe, efficacious for VKC in children

02 Jun 2026

Gestational weight gain tied to poor cognitive development in children

02 Jun 2026

Gestational weight gain (GWG) and its trajectories influence neurodevelopment in children, reports a study, noting that this modifiable factor can guide early intervention for high-risk mother‒child dyads.

Gestational weight gain tied to poor cognitive development in children

02 Jun 2026

Pulpotomy fares better than selective dental caries removal

02 Jun 2026 by

A study conducted by researchers at the National University of Singapore shows that a full pulpotomy is more effective than selective caries removal (SCR) for avoiding further intervention over 3 years in teeth with extensive caries, most of which were extremely deep lesions.

Pulpotomy fares better than selective dental caries removal

02 Jun 2026

Olive leaf extract plus potassium may have cardiometabolic protective effect

02 Jun 2026

The combination of olive leaf extract (OLE) and potassium appears to exert favourable effects on blood pressure (BP), lipid profile, oxidative status, and insulin sensitivity in individuals with mild to moderate BP elevation, according to a small study.

Olive leaf extract plus potassium may have cardiometabolic protective effect

02 Jun 2026

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

New-found anti-ageing effects of GLP-1 RAs can potentially improve severe stroke recovery

New-found anti-ageing effects of GLP-1 RAs can potentially improve severe stroke recovery

Award-winning world-first nasal spray as prehospital emergency aid for ischaemic stroke

Award-winning world-first nasal spray as prehospital emergency aid for ischaemic stroke

Mainland China’s healthcare surge and HK’s edge: A powerful synergy

Mainland China’s healthcare surge and HK’s edge: A powerful synergy

Astegolimab gets mixed results in COPD

Astegolimab gets mixed results in COPD

Leflunomide–hydroxychloroquine’s efficacy in Sjögren’s disease confirmed in RepurpSS-II trial

Leflunomide–hydroxychloroquine’s efficacy in Sjögren’s disease confirmed in RepurpSS-II trial

Can HF patients with obesity undergo metabolic, bariatric procedures?

Can HF patients with obesity undergo metabolic, bariatric procedures?

Corticosteroid-sparing topical treatments safe, efficacious for VKC in children

Corticosteroid-sparing topical treatments safe, efficacious for VKC in children

Gestational weight gain tied to poor cognitive development in children

Gestational weight gain tied to poor cognitive development in children

Pulpotomy fares better than selective dental caries removal

Pulpotomy fares better than selective dental caries removal

Olive leaf extract plus potassium may have cardiometabolic protective effect

Olive leaf extract plus potassium may have cardiometabolic protective effect